Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Siv L. Leknes"'
Autor:
Maria Riedel, Mikkel H. Vendelbo, Martin F. Berthelsen, Siv L. Leknes, Mette Abildgaard Pedersen, Henrik Hager, Martin K. Thomsen, Justin V Joseph
Publikováno v:
Berthelsen, M F, Leknes, S L, Riedel, M, Pedersen, M A, Joseph, J V, Hager, H, Vendelbo, M H & Thomsen, M K 2021, ' Comparative analysis of Stk11/Lkb1 versus Pten deficiency in lung adenocarcinoma induced by CRISPR/Cas9 ', Cancers, vol. 13, no. 5, 974 . https://doi.org/10.3390/cancers13050974
Cancers
Berthelsen, M F, Leknes, S L, Riedel, M, Pedersen, M A, Joseph, J V, Hager, H, Vendelbo, M H & Thomsen, M K 2021, ' Comparative analysis of stk11/lkb1 versus pten deficiency in lung adenocarcinoma induced by crispr/cas9 ', Cancers, vol. 13, no. 5, 974 . https://doi.org/10.3390/cancers13050974
Volume 13
Issue 5
Cancers, Vol 13, Iss 974, p 974 (2021)
Cancers
Berthelsen, M F, Leknes, S L, Riedel, M, Pedersen, M A, Joseph, J V, Hager, H, Vendelbo, M H & Thomsen, M K 2021, ' Comparative analysis of stk11/lkb1 versus pten deficiency in lung adenocarcinoma induced by crispr/cas9 ', Cancers, vol. 13, no. 5, 974 . https://doi.org/10.3390/cancers13050974
Volume 13
Issue 5
Cancers, Vol 13, Iss 974, p 974 (2021)
Simple Summary Lung cancer is by far the leading cause of cancer induced mortality worldwide with a median five-year survival rate of 19 percent. Genome sequencing of lung cancer samples has revealed several key mutated genes, which could be implicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdee9b431fc94878ab9355a9de3b557c
https://pure.au.dk/portal/da/publications/comparative-analysis-of-stk11lkb1-versus-pten-deficiency-in-lung-adenocarcinoma-induced-by-crisprcas9(879a46bc-347a-493b-b388-c64a846f769c).html
https://pure.au.dk/portal/da/publications/comparative-analysis-of-stk11lkb1-versus-pten-deficiency-in-lung-adenocarcinoma-induced-by-crisprcas9(879a46bc-347a-493b-b388-c64a846f769c).html
Autor:
Maria Riedel, Eric Perouzel, Siv L. Leknes, Huiqiang Cai, Cedric Boularan, Thierry Lioux, Morten K Skouboe, Michele Tiraby, Martin K. Thomsen, Fabienne Vernejoul, Martin F. Berthelsen, Justin V Joseph, Mikkel H. Vendelbo, Søren R. Paludan
Publikováno v:
Thomsen, M K, Skouboe, M K, Boularan, C, Vernejoul, F, Lioux, T, Leknes, S L, Berthelsen, M F, Riedel, M, Cai, H, Joseph, J V, Perouzel, E, Tiraby, M, Vendelbo, M H & Paludan, S R 2020, ' The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma ', Oncogene, vol. 39, no. 8, pp. 1652-1664 . https://doi.org/10.1038/s41388-019-1108-8
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, and the incidence of HCC is increasing. Recently, cancer immunotherapy has emerged as an efficient treatment against some cancers. Here we have used a mouse model of mutagen-indu